Gene therapy progress and prospects: adenoviral vectors.
about
A complementation method for functional analysis of mammalian genesGene therapy: light is finally in the tunnelAdenovirus-mediated efficient gene transfer into cultured three-dimensional organoidsQuantitative comparison of constitutive promoters in human ES cellsBarriers to inhaled gene therapy of obstructive lung diseases: A reviewAdenovirus vector production using low-multiplicity infection of 293 cells.Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand?Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice.Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta.Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model.AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis modelClostridia in cancer therapy.Current strategies and future directions for eluding adenoviral vector immunityGene therapy using hepatocyte growth factor expressing adenovirus improves skin flap survival in a rat model.Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis.Advances in Gene Delivery Systems.Gene therapy for renal disorders.Prospects for gene therapy of haemophilia.Down-regulation of IL-8 expression in human airway epithelial cells through helper-dependent adenoviral-mediated RNA interference.Gene therapy for proliferative ocular diseases.Current status and prospects for gene therapy.Gene therapy progress and prospects: gene therapy for diabetes mellitus.An Engineered Endomorphin-2 Gene for Morphine Withdrawal SyndromeEx vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig.Endostatin gene therapy for liver cancer by a recombinant adenovirus deliveryAdrenomedullin: angiogenesis and gene therapy.Versatility of gene therapy vectors through viruses.Cell-specific targeting of lipid-based carriers for ODN and DNA.Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.Stimuli-responsive polymers in gene delivery.New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genesActivation of iCaspase-9 in neovessels inhibits oral tumor progression.Immune cell recruitment and cell-based system for cancer therapy.Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors.Regulation of fertilization in male rats by CatSper2 knockdown.Emerging cancer vaccines: the promise of genetic vectors.Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia proteinImmunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain.Transcriptional targeting of tumor endothelial cells for gene therapy.
P2860
Q24810368-3AFEFFB4-1BD9-4478-B712-EDE9E9282978Q27000091-C6BA98F1-DE62-4490-B2F2-6916406E7EE3Q27346564-A04B1E65-79D1-46F1-883D-ED9A0E02298CQ28475300-28114879-D393-4AB6-8E84-AD8C2DB5A556Q29248141-E6448FA7-B699-4376-94F9-80E19DD7BF1CQ30482293-B3BF8C8D-81CA-4731-BCE1-791677D1E641Q30489689-319593CB-AC6A-472C-B108-D96EAEE98E5EQ31136160-98EC4278-D8FB-4FC4-BA11-C351E10DCB42Q33221159-532796C0-DA28-49F3-9CD2-042A8C31679DQ33767313-D729567E-4394-4111-968E-CE90B85B4C70Q33920953-9A70FE81-DBEE-4A60-B539-5C9328EF9508Q34214323-FB4A190D-8A0D-418C-9298-296F4A3CCFA0Q34307573-58AEB932-85A6-4747-B353-E90F6841972BQ34585554-77BD0914-ED8F-4847-82E7-43C754F0404CQ34588837-0664D4EC-7D48-4516-BF82-BA4333E076D9Q35554334-CB389D76-8DAA-48E1-A20B-B8A403C1B633Q35632772-AA350604-C83C-4E8E-AE3B-DDD73679C80AQ35790872-515A50C6-073D-4BDD-9391-C92D43F37092Q35824841-EE5C51B3-978D-448D-92E0-A8DB47E53A4BQ35836325-389A97F8-2E4C-40B6-BB6D-200E1CB3CD02Q35842653-C4133C7F-A409-4C3A-B76C-6577C1217D41Q35881934-ACBD9019-9643-43AE-A2A3-8C846EB8E6A4Q35924387-6E608602-77D0-4080-85E8-F226E244B6DEQ35966106-1DF7818F-CFF7-4591-A683-A5DDD41F4DD0Q36014104-690236D5-B975-4927-9DAD-78E3D3DB2F7DQ36065853-3287C150-712C-4661-B933-27ED5ED2007DQ36123384-748843E5-7CE6-45FE-94BA-2050E777A204Q36150489-A1A6483A-3155-4BFB-90EB-42149FAE1A98Q36272601-B617B57A-B21A-4456-9A2D-B1C9F7BC2852Q36288920-F86FB060-2923-4119-83AE-03B5D35F663FQ36315150-19C911E8-BE25-47C1-B666-74D11FCED885Q36385632-D6CCE0D4-1425-4433-987A-E857C1D31311Q36417732-3067A033-52B4-4B7E-8538-C88B9BF34076Q36517706-BC839038-6B85-4AD7-8232-FD8B08943ADEQ36893512-D9F7A86D-4502-4047-9283-E8AF71481BF8Q37074420-8DB5D0AF-100B-46CB-B001-389D70CF1B2FQ37137464-41C32BE5-B2F0-4B72-BD97-B351F078375BQ37290808-C81866C1-0A39-495A-8CFC-2494B6605D41Q37388717-D81DE875-D03B-41C5-B664-632818981A2FQ37459648-0319C6FB-B649-4FA8-9AFC-9EBED07A5677
P2860
Gene therapy progress and prospects: adenoviral vectors.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gene therapy progress and prospects: adenoviral vectors.
@ast
Gene therapy progress and prospects: adenoviral vectors.
@en
type
label
Gene therapy progress and prospects: adenoviral vectors.
@ast
Gene therapy progress and prospects: adenoviral vectors.
@en
prefLabel
Gene therapy progress and prospects: adenoviral vectors.
@ast
Gene therapy progress and prospects: adenoviral vectors.
@en
P2860
P356
P1433
P1476
Gene therapy progress and prospects: adenoviral vectors.
@en
P2093
St George JA
P2860
P2888
P304
P356
10.1038/SJ.GT.3302071
P577
2003-07-01T00:00:00Z